| scholarly article | Q13442814 |
| P2093 | author name string | Susan Martin | |
| Dalia M. Al-Husseini | |||
| Judith E. Worthington | |||
| Philip A. Dyer | |||
| Robert W. G. Johnson | |||
| P2860 | cites work | Anti-HLA antibodies after solid organ transplantation | Q33856062 |
| Posttransplant antidonor lymphocytotoxic antibody production in relation to graft outcome | Q68166622 | ||
| The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection | Q68704052 | ||
| Posttransplant antidonor antibodies and graft rejection. Evaluation by two-color flow cytometry | Q69486597 | ||
| Enzyme-linked immunoassay for anti-HLA antibodies--an alternative to panel studies by lymphocytotoxicity | Q70529151 | ||
| The humoral immune response towards HLA class II determinants in renal transplantation | Q71769742 | ||
| Sensitization to HLA antigens occurs in 95% of primary renal transplant rejections | Q72602887 | ||
| A comparison of enzyme-linked immunoabsorbent assays and flow cytometry techniques for the detection of HLA specific antibodies | Q74618588 | ||
| Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation | Q77736829 | ||
| Comparison between enzyme-linked immunosorbent assay and cytotoxic cross-match procedures for detecting IgG anti-donor antibodies | Q77781388 | ||
| Kidney graft failure and presensitization against HLA class I and class II antigens | Q78021242 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1034-1040 | |
| P577 | publication date | 2003-04-01 | |
| 2003-04-15 | |||
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome | |
| Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome1 | |||
| P478 | volume | 75 |
| Q26996813 | Allograft rejection and tubulointerstitial fibrosis in human kidney allografts: interrogation by urinary cell mRNA profiling |
| Q79150234 | Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeys |
| Q38481656 | Anti-human leukocyte antigen DQ antibodies in renal transplantation: Are we underestimating the most frequent donor specific alloantibodies? |
| Q47556078 | Antibody mediated rejection due to de-novo DSA causing venous thrombosis of pancreas allograft - A case report |
| Q37904197 | Antibody-mediated allograft rejection: the emerging role of endothelial cell signalling and transcription factors. |
| Q36263023 | Antibody-mediated organ-allograft rejection |
| Q33930084 | Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipients |
| Q46095776 | Association of high post-transplant soluble CD30 serum levels with chronic allograft nephropathy. |
| Q47762688 | Binding of anti-HLA class I antibody to endothelial cells produce an inflammatory cytokine secretory pattern |
| Q37058050 | Chronic alloantibody mediated rejection |
| Q84238174 | Chronic rejection of human kidney allografts |
| Q90450246 | Circulating B Cells With Memory and Antibody-Secreting Phenotypes Are Detectable in Pediatric Kidney Transplant Recipients Before the Development of Antibody-Mediated Rejection |
| Q104802057 | Clinical and Pathologic Feature of Patients With Early Versus Late Active Antibody-Mediated Rejection After Kidney Transplantation: A Single-Center Experience |
| Q46719552 | Clinical relevance of low levels of preformed alloantibodies detected by flow cytometry in the first year post-kidney transplantation |
| Q83061041 | Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA |
| Q49917211 | Comparison Between Total IgG, C1q, and C3d Single Antigen Bead Assays in Detecting Class I Complement-Binding Anti-HLA Antibodies |
| Q37802561 | De novo anti-HLA antibodies in renal allograft recipients: a cross-section study. |
| Q82343270 | Detection of donor-specific HLA antibodies before and after removal of a rejected kidney transplant |
| Q38508013 | Detection of donor-specific anti-HLA class I and II antibodies using antibody monitoring system |
| Q37308415 | Differential effects of donor-specific alloantibody |
| Q79854817 | Distribution of donor-specific antibodies in the cortex and the medulla of renal transplants with chronic allograft nephropathy |
| Q42211166 | Does the KDIGO CKD risk stratification based on GFR and proteinuria predict kidney graft failure? |
| Q47722275 | Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation |
| Q89965614 | Effect of Optimized Immunosuppression (Including Rituximab) on Anti-Donor Alloresponses in Patients With Chronically Rejecting Renal Allografts |
| Q35124576 | Emerging role of B cells in chronic allograft dysfunction |
| Q36575860 | Enhanced de novo alloantibody and antibody-mediated injury in rhesus macaques |
| Q79819422 | Experience with cyclosporine |
| Q37196119 | Five-year clinical effects of donor bone marrow cells infusions in kidney allograft recipients: improved graft function and higher graft survival |
| Q33207800 | Flow cytometric detection of complement-activating HLA antibodies |
| Q37485481 | Four stages and lack of stable accommodation in chronic alloantibody-mediated renal allograft rejection in Cynomolgus monkeys |
| Q37601515 | Graft dysfunction in chronic antibody-mediated rejection correlates with B-cell-dependent indirect antidonor alloresponses and autocrine regulation of interferon-γ production by Th1 cells. |
| Q35942851 | High-dose immunosuppressant alters the immunological status of New Zealand white rabbits following skin transplantation |
| Q48112929 | Human Leukocyte Antigen Sensitization in Solid Organ Transplantation: A Primer on Terminology, Testing, and Clinical Significance for the Apheresis Practitioner. |
| Q45963224 | Human leukocyte antigen and major histocompatibility complex class I-related chain A antibodies after kidney transplantation in Turkish renal transplant recipients. |
| Q37813414 | Immune monitoring and biomarkers to predict chronic allograft dysfunction |
| Q37766166 | Immunogenicity and allogenicity: a challenge of stem cell therapy |
| Q47800223 | Immunoglobulin isotype switching of antibodies to vimentin is associated with development of transplant glomerulopathy following human renal transplantation |
| Q35583546 | Immunologic monitoring. |
| Q36696536 | Immunological risk assessment and human leukocyte antigen antibody testing in kidney transplantation |
| Q46245832 | Impact of the presence and duration of donor-specific antibodies on renal function |
| Q37375622 | Incidence and clinical significance of de novo donor specific antibodies after kidney transplantation |
| Q89594061 | Inverse Association Between the Quantity of Human Peripheral Blood CXCR5+IFN-γ+CD8+T cells with De Novo DSA Production in the First Year After Kidney Transplant |
| Q35153318 | Late kidney allograft loss: what we know about it, and what we can do about it |
| Q39808031 | Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study |
| Q36480289 | Management of patients after renal graft loss: an open question for nephrologists. |
| Q84456399 | Minimising the clinical impact of the alloimmune response through effective histocompatibility testing for organ transplantation |
| Q37898509 | New therapeutic approaches to antibody-mediated rejection in renal transplantation |
| Q44215754 | Predicting renal graft failure by sCD30 levels and de novo HLA antibodies at 1year post-transplantation |
| Q37723175 | Prevalence and risk factors for early chronic allograft nephropathy in a live related renal transplant program |
| Q83220154 | Prevalence of HLA antibodies and its impact on graft function in a group of kidney transplant recipients: a cross-sectional study |
| Q33722343 | Prolongation of Cardiac Allograft Survival by Endometrial Regenerative Cells: Focusing on B-Cell Responses |
| Q30544649 | Pros and cons for C4d as a biomarker |
| Q39160359 | Regulatory B cells: Phenotype, function and role in transplantation |
| Q27015093 | Regulatory B cells: an exciting target for future therapeutics in transplantation |
| Q41810263 | Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy |
| Q64982205 | Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy. |
| Q37300446 | Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes |
| Q104134305 | Safety and Efficacy of a Steroid Avoidance Immunosuppression Regimen in Renal Transplant Patients With De Novo or Preformed Donor-Specific Antibodies: A Single-Center Study |
| Q80185032 | Significance of anti-HLA and donor-specific antibodies in long-term renal graft survival |
| Q81813237 | Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection |
| Q43166913 | Successful renal re-transplantation in the presence of pre-existing anti-DQ5 antibodies when there was zero mismatch at class I human leukocyte antigen A, B, & C: a case report |
| Q36644337 | The Peripheral NK Cell Repertoire after Kidney Transplantation is Modulated by Different Immunosuppressive Drugs |
| Q54325461 | The correlation of HLA allele frequencies and HLA antibodies in sensitized kidney transplantation candidates. |
| Q44613788 | The effect of anti-human leukocyte antigen, anti-major histocompatibility complex class 1 chain-related antigen a, and anti-glutathione transferase-T1 antibodies on the long-term survival of renal allograft |
| Q43805381 | The impact of de novo donor-specific anti-human leukocyte antigen antibodies on 5-year renal transplant outcome |
| Q35223952 | The link between major histocompatibility complex antibodies and cell proliferation |
| Q37813404 | The pathology of chronic allograft dysfunction |
| Q38048605 | The role of complement in antibody-mediated rejection in kidney transplantation |
| Q38205229 | Transplant glomerulopathy: the interaction of HLA antibodies and endothelium |
| Q27021397 | Treatment options and strategies for antibody mediated rejection after renal transplantation |
| Q51738986 | Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant. |
| Q35790601 | Utility of HLA Antibody Testing in Kidney Transplantation |
Search more.